Table 1 Clinical and pathological characteristics of mismatch repair intact endometrial carcinoma cohort
Characteristics (n = 132) | Value |
|---|---|
Age, median (range), years | 60 (27–88) |
Tumor size, median (range), mm | 35 (10–145) |
FIGO tumor stage, n (%) | |
I | 112 (85) |
II | 5 (4) |
III | 13 (10) |
IV | 2 (1) |
Any myometrial invasion, n (%) | |
Yes | 95 (72) |
No | 37 (28) |
Myometrial invasion ≥50%, n (%) | |
Yes | 30 (23) |
No | 102 (77) |
Lymphovascular space invasion, n (%) | |
Yes | 30 (23) |
No | 102 (77) |
Metastasis to pelvic lymph nodes, n (%) | |
Yes | 11 (8) |
No | 77 (58) |
Lymph node dissection not performed | 44 (33) |
Metastasis to para-aortic lymph nodes, n (%) | |
Yes | 5 (4) |
No | 46 (35) |
Lymph node dissection not performed | 81 (61) |
PTEN immunohistochemistry | |
Positive | 65 (49) |
Heterogeneous | 8 (6) |
Negative | 59 (45) |
